Search Results 191-200 of 16737 for alt

1. A Study to Collect Information about Biomarkers (Lab Test Results) that May Help to Predict Which People with Calf Vein Clots May be at Higher or Lower Risk of Having the Clot Grow or Progress - Mayo Clinic

   Significant liver disease (e.g. acute hepatitis, chronic active hepatitis, cirrhosis) or ALT > 3 x ULN. (within last two weeks); Platelet count < 50 x109/L ...

2. Health Topics - Mayo Clinic News Network

   The burden of cancer is different for everyone, and life stages can play a role in how it affects people. For adolescents and young adults[...] ...

3. Liver transplant - Doctors & Departments - Mayo Clinic

   2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...

4. Liver transplant - Doctors & Departments - Mayo Clinic

   2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...

5. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Cirrhosis - Mayo Clinic

   Evidence of significant worsening of ALT, AST or bilirubin during the Screening Period, in the opinion of the investigator or medical monitor;; A centrally read ...

6. Liver transplant - Doctors & Departments - Mayo Clinic

   2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...

7. Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors - Mayo Clinic

   Aspartate aminotransferase/alanine aminotransferase (AST/ALT) ≤ 3 upper limit of normal (ULN). In cases with liver involvement ALT/ AST ≤ 5× ULN. Total ...

8. A Study To Evaluate LOXO-305 Vs. Approved BTK Inhibitor Approved Drugs To Treat Patients With Mantle Cell Lymphoma - Mayo Clinic

   AST and ALT ≤ 3.0 x upper limit of normal (ULN). Total bilirubin ≤ 1.5 x ULN. Creatinine clearance of ≥ 30 mL/min according to Cockcroft/Gault Formula ...

9. A Study of a Personalized Neoantigen Cancer Vaccine - Mayo Clinic

   ALT and AST ≤ 3 × ULN unless liver metastases are present in which case patients are included; if ALT and AST ≤ 5 × ULN;; Total bilirubin ≤ 1.5 × ULN; OR ...

10. Selinexor in Advanced Liposarcoma - Clinical Trials

    ... (ALT) <3.0 x ULN (except patients with liver involvement of their liposarcoma who must have an AST and ALT ≤5 x ULN);; Adequate renal function: Serum ...